Center for Scientific Review; Notice of Closed Meetings, 76367-76368 [2016-26451]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 212 / Wednesday, November 2, 2016 / Notices
investigations to determine the
condition of Tribal health facilities; (6)
serves as the principal advisor regarding
the real property management program
which oversees owned and leased real
property and General Services
Administration (GSA) assigned space;
interacts with GSA Region IX and
Engineering Services to ensure
adequacy of facilities; and (7)
coordinates property management
activities including space assignments,
space need determinations, regulatory
compliance, and reporting.
Environmental Health Services Division
(GFGAD1)
(1) Maintains relationships with other
Federal agencies and Tribes to
maximize responses to environmental
health issues and maximize benefits to
Tribes by coordinating program efforts;
(2) identifies environmental health
needs of AI/AN populations and
supports efforts to build Tribal capacity;
(3) provides personnel support services
and advocates for environmental health
providers; and (4) performs functions
related to environmental health
programs such as injury prevention,
emergency response, water quality, food
sanitation, occupational health and
safety, solid and hazardous waste
management, environmental health
issues in health care and non-health
care institutions, and vector control.
sradovich on DSK3GMQ082PROD with NOTICES
Sanitation Facilities Construction
Division (GFGAD2)
(1) Manages the environmental
engineering programs, including the
Sanitation Facilities Construction (SFC)
program, and compliance activities
associated with environmental
protection and historic preservation
legislation; (2) consults with Tribal
groups/organizations in the
development and implementation of
SFC policies and initiatives, and in the
identification of sanitation needs for
single family housing and community
facilities; and (3) works closely with
other Federal agencies to resolve
environmental issues and maximize
benefits to Tribes by coordinating
program efforts.
OEHE District Offices/Field Offices
Redding District Office—GFGAD2A
Arcata Field Office—GFGAD2A1
Sacramento District Office—GFGAD2B
Ukiah Field Office—GFGAD2B1
Clovis Field Office—GFGAD2B2
Escondido District Office—GFGAD2C
(1) Implements the SFC and
Environmental Health Services
responsibilities; (2) serves as the
principal advisor to communities,
individuals, contractors, and other
VerDate Sep<11>2014
17:18 Nov 01, 2016
Jkt 241001
organizations on all matters pertaining
to SFC and Environmental Health
Services; (3) implements activities that
assist all health programs to attain
accreditation by appropriate accrediting
agencies; (4) implements the area
fluoridation and operation and
maintenance activities, and (5)
implements the provision of sanitation
facilities for new housing projects
sponsored by other government agencies
and for existing housing.
Health Facilities Engineering Division
(GFGAD3)
(1) Develops, implements, and
manages the programs affecting health
care facilities operations, including
routine maintenance and improvement,
real property asset management, realty,
facilities environmental, quarters, and
clinical engineering programs; (2) serves
as the principal resource for
coordination of facilities operations and
provides consultation to IHS and the
Tribes on health care facilities
operations; and (3) monitors the
improvement, alteration, and repair of
health care facilities.
Desert Sage Youth Wellness Center—
GFGAE
(1) The Desert Sage Youth Wellness
Center in Southern California provides
inpatient substance abuse and alcohol
treatment to eligible AI/AN youth as a
Youth Regional Treatment Center
(YRTC) and will help California Tribal
youth find healthy directions in life;
and (2) in addition to providing
treatment services, the YRTC will work
with Tribal and urban Indian programs
to help provide a continuum of care,
including preventive and aftercare
services.
Sacred Oaks Healing Center—GFGAF
76367
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–218
Provocative Questions in Pediatric Cancer.
Date: November 8, 2016.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Charles Morrow, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–451–
4467, morrowcs@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
(1) The Sacred Oaks Healing Center in
Northern California provides inpatient
substance abuse and alcohol treatment
to eligible AI/AN youth as a YRTC and
will help California Tribal youth find
healthy directions in life; and (2) in
addition to providing treatment
services, the YRTC will work with
Tribal and urban Indian programs to
help provide a continuum of care,
including preventive and aftercare
services.
Dated: October 28, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Dated: October 25, 2016.
Elizabeth A. Fowler,
Deputy Director for Management Operations,
Indian Health Service.
Center for Scientific Review; Notice of
Closed Meetings
[FR Doc. 2016–26488 Filed 11–1–16; 8:45 am]
BILLING CODE 4165–16–P
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
[FR Doc. 2016–26452 Filed 11–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
E:\FR\FM\02NON1.SGM
02NON1
76368
Federal Register / Vol. 81, No. 212 / Wednesday, November 2, 2016 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
121 Early-Stage Preclinical Validation of
Therapeutic Leads for Diseases of Interest to
the NIDDK (R01).
Date: November 17–18, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Antonello Pileggi, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
Bethesda, MD 20892–7892, (301) 402–6297,
pileggia@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
121 Early-Stage Preclinical Validation of
Therapeutic Leads for Diseases of Interest to
the NIDDK (R01).
Date: November 17, 2016.
Time: 11:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Hui Chen, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, 301–435–1044,
chenhui@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Vasular and
Hematology: Molecular and Cellular
Hematology.
Date: November 30, 2016.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0952, espinozala@mail.nih.gov.
VerDate Sep<11>2014
17:18 Nov 01, 2016
Jkt 241001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Risk, Prevention and Health
Behavior.
Date: December 1–2, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Claire E. Gutkin, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106,
MSC 7808, Bethesda, MD 20892, 301–594–
3139, gutkincl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Digestive Diseases.
Date: December 1–2, 2016.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jianxin Hu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2156,
Bethesda, MD 20892, 301–827–4417,
jianxinh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Kidney and Urology.
Date: December 1, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Aiping Zhao, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm 2188, MSC
7818, Bethesda, MD 20892–7818, (301) 435–
0682, zhaoa2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA:
Immunology.
Date: December 1, 2016.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review (CSR), National Institutes
of Health (NIH), 6701 Rockledge Dr., Room
4203, Bethesda, MD 20817, (301) 435–3566,
alok.mulky@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR16–027:
Commercialization Readiness Pilot.
Date: December 2, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott at Metro
Center, 775 12th Street NW., Washington, DC
20005.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Contact Person: Cristina Backman, Ph.D.,
Scientific Review Officer, ETTN IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7846, Bethesda, MD 20892, cbackman@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Mechanisms of Bacterial
Virulence and Pathogenesis.
Date: December 2, 2016.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 27, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–26451 Filed 11–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Public Health Service
Applications and Pre-Award Reporting
Requirements (Office of the Director)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Ms. Mikia P. Currie, Program
SUMMARY:
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 81, Number 212 (Wednesday, November 2, 2016)]
[Notices]
[Pages 76367-76368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26451]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
[[Page 76368]]
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-121 Early-Stage Preclinical Validation of Therapeutic
Leads for Diseases of Interest to the NIDDK (R01).
Date: November 17-18, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Antonello Pileggi, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166, Bethesda, MD 20892-7892,
(301) 402-6297, pileggia@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-121 Early-Stage Preclinical Validation of Therapeutic
Leads for Diseases of Interest to the NIDDK (R01).
Date: November 17, 2016.
Time: 11:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Hui Chen, MD, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, 301-435-1044, chenhui@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Vasular and Hematology: Molecular and Cellular Hematology.
Date: November 30, 2016.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301-435-
0952, espinozala@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Risk, Prevention and Health Behavior.
Date: December 1-2, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Claire E. Gutkin, MPH, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106, MSC 7808, Bethesda, MD
20892, 301-594-3139, gutkincl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Digestive Diseases.
Date: December 1-2, 2016.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2156, Bethesda, MD 20892, 301-827-4417,
jianxinh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Kidney and Urology.
Date: December 1, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Aiping Zhao, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Rm 2188, MSC 7818, Bethesda, MD 20892-7818, (301)
435-0682, zhaoa2@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA: Immunology.
Date: December 1, 2016.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alok Mulky, Ph.D., Scientific Review Officer,
Center for Scientific Review (CSR), National Institutes of Health
(NIH), 6701 Rockledge Dr., Room 4203, Bethesda, MD 20817, (301) 435-
3566, alok.mulky@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR16-027: Commercialization Readiness Pilot.
Date: December 2, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott at Metro Center, 775 12th Street NW.,
Washington, DC 20005.
Contact Person: Cristina Backman, Ph.D., Scientific Review
Officer, ETTN IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 5211, MSC 7846, Bethesda, MD
20892, cbackman@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Mechanisms of Bacterial Virulence
and Pathogenesis.
Date: December 2, 2016.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, 301-435-
1167, pandyaga@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 27, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-26451 Filed 11-1-16; 8:45 am]
BILLING CODE 4140-01-P
